IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and ...

Companion Animal Practices are projected to dominate practice types due to high pet ownership rates and increasing healthcare ...

STRATEGY OVERVIEW The Gabelli Pet Parents' Fund seeks to provide capital appreciation. Under normal market conditions, the Fund invests at least 80% of its net assets in common and preferred ...

IDEXX Laboratories (NasdaqGS:IDXX) recently introduced its Catalyst® Cortisol Test, an advance in veterinary diagnostics, and reported an earnings growth with a raised revenue guidance for 2025 ...

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced the launch of the Catalyst® Cortisol Test, which measures real-time quantitative cortisol ...

IDEXX Laboratories Inc. (NASDAQ:IDXX) is among the 12 best healthcare stocks. On June 11, Leerink Partners analyst Daniel Clark reiterated an Outperform rating on the stock.

IDEXX Laboratories Inc. (NASDAQ:IDXX) is among the 12 best healthcare stocks. On June 11, Leerink Partners analyst Daniel Clark reiterated an Outperform rating on the stock. However, the analyst ...

Shares of IDEXX Laboratories Inc. IDXX slid 1.55% to $520.59 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index SPX falling 0.84% to ...

IDEXX Laboratories, a global leader in veterinary diagnostics with a market capitalization of $42.6 billion, has reached a new 52-week high, with its stock price soaring to $530.61.

Lucknow: With Kalyan Singh Super Speciality Cancer Institute & Hospital set to launch a telemedicine service, cancer patients from 10 districts of.

Review IDEXX Laboratories Inc (IDXX:XNAS) stock and the current sustainability and ESG risk rating to help with your investing decisions.